Research
Feb 17, 2021 | News
Sponsored by the National Institutes of Health (NIH), the HIV Prevention Trials Network (HPTN) and the HIV Vaccine Trials Network (HVTN) jointly conducted the Antibody Mediated Prevention (AMP) study which tested a new innovation for HIV prevention. Traditionally,...
Feb 10, 2021 | In the Media, News
In light of a viral misrepresentation of a WHO press release alleged to show that polymerase chain reaction (PCR) tests for COVID-19 caused large scale false positives, ICAP’s Wafaa El-Sadr, MD, MPH, MPA was cited as a public health expert in a recent Fact Check...
Feb 5, 2021 | In the Media, News
A recent profile in the Morningside Post highlights the career accomplishments of Wafaa El-Sadr, MD, MPH, MPA — ICAP’s founder and director—and how her past experiences in the early days of the HIV response relate to her ongoing work as a leader in the global...
Jan 22, 2021 | In the Media, News
In this episode of the Inspired Service Podcast, host Noah Sheinbaum speaks with Yen Pottinger, senior lab advisor at ICAP and former HIV Incidence Team lead at the Centers for Disease Control and Prevention. They explore the brilliance of the virus itself, discuss...
Jan 19, 2021 | In the Media, News
ICAP’s Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, returned to WNYC’s Brian Lehrer Show on Jan 11 to discuss the latest COVID-19 research and to answer questions from the audience. When asked about those who should be prioritized for getting the...